findmyKOL
Clinical trialNCT04596033TerminatedPhase 1Interventional

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

SponsorGenocea Biosciences, Inc.Enrollment49Anal Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaMelanomaMerkel Cell CarcinomaNon-small Cell Lung CancerRenal Cell Carcinoma+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Banner Md Anderson Cancer Center

    Gilbert, Arizona, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • University of Chicago Medical Center

    Chicago, Illinois, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Sarah Cannon Research Institute

    Nashville, Tennessee, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Nov 2020
Primary completion
27 Jun 2022
Completion
27 Jun 2022
Last update posted
15 Jul 2022
Registered enrollment
49
Registry id
NCT04596033

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.